Show simple item record

dc.contributor.authorKasper, B
dc.contributor.authorAchee, A
dc.contributor.authorSchuster, K
dc.contributor.authorWilson, R
dc.contributor.authorvan Oortmerssen, G
dc.contributor.authorGladdy, RA
dc.contributor.authorHemming, ML
dc.contributor.authorHuang, P
dc.contributor.authorIngham, M
dc.contributor.authorJones, RL
dc.contributor.authorPollack, SM
dc.contributor.authorReinke, D
dc.contributor.authorSanfilippo, R
dc.contributor.authorSchuetze, SM
dc.contributor.authorSomaiah, N
dc.contributor.authorVan Tine, BA
dc.contributor.authorWilky, B
dc.contributor.authorOkuno, S
dc.contributor.authorTrent, J
dc.date.accessioned2021-04-08T13:53:05Z
dc.date.available2021-04-08T13:53:05Z
dc.date.issued2021-02-20
dc.identifier.citationCancers, 2021, 13 (4)
dc.identifier.issn2072-6694
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4505
dc.identifier.eissn2072-6694
dc.identifier.doi10.3390/cancers13040886
dc.description.abstractAs leiomyosarcoma patients are challenged by the development of metastatic disease, effective systemic therapies are the cornerstone of outcome. However, the overall activity of the currently available conventional systemic treatments and the prognosis of patients with advanced or metastatic disease are still poor, making the treatment of this patient group challenging. Therefore, in a joint effort together with patient networks and organizations, namely Sarcoma Patients EuroNet (SPAEN), the international network of sarcoma patients organizations, and the National LeioMyoSarcoma Foundation (NLMSF) in the United States, we aim to summarize state-of-the-art treatments for leiomyosarcoma patients in order to identify knowledge gaps and current unmet needs, thereby guiding the community to design innovative clinical trials and basic research and close these research gaps. This position paper arose from a leiomyosarcoma research meeting in October 2020 hosted by the NLMSF and SPAEN.
dc.formatElectronic
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleUnmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN).
dc.typeJournal Article
dcterms.dateAccepted2021-02-15
rioxxterms.versionVoR
rioxxterms.versionofrecord10.3390/cancers13040886
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2021-02-20
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfCancers
pubs.issue4
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular and Systems Oncology
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular and Systems Oncology
pubs.publication-statusPublished
pubs.volume13
pubs.embargo.termsNot known
icr.researchteamMolecular and Systems Oncology
icr.researchteamMolecular and Systems Oncologyen_US
dc.contributor.icrauthorHuang, Paulen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0